CM101, A NOVEL MONOCLONAL ANTIBODY TARGETING CCL24, IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: RESULTS FROM SPRING STUDY

Authors
Category Primary study
ConferenceGut
Year 2025
This article has no abstract
Epistemonikos ID: 56b903b0130c8c2f3708672af4014315e2435f47
First added on: Apr 30, 2026